Thus it is not surprising that there are data suggesting that a proportion of sporadic basal-like breast cancers may have a dysfunctional BRCA1 pathway, due to gene promoter methylation or transcriptional inactivation [13], [14]. This evidence concerns the gene BRCA1 and breast carcinoma.